NCT06004180View on ClinicalTrials.gov

A Trial Investigating Lu AF28996 in Adult Japanese Participants With Parkinson's Disease (PD)

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

September 12, 2023

Primary Completion Date

November 21, 2023

Study Completion Date

November 21, 2023

Conditions
Parkinson Disease
Interventions
DRUG

Lu AF28996

Hard capsule, orally, per schedule specified in the arm description.

Trial Locations (1)

791-0295

Ehime University Hospital, Ehime

All Listed Sponsors
lead

H. Lundbeck A/S

INDUSTRY

NCT06004180 - A Trial Investigating Lu AF28996 in Adult Japanese Participants With Parkinson's Disease (PD) | Biotech Hunter | Biotech Hunter